Radial scars and subsequent breast cancer risk: results from the Nurses' Health Studies

被引:31
作者
Aroner, Sarah A. [1 ]
Collins, Laura C. [2 ,3 ]
Connolly, James L. [2 ,3 ]
Colditz, Graham A. [4 ]
Schnitt, Stuart J. [2 ,3 ]
Rosner, Bernard A. [3 ,5 ,6 ]
Hankinson, Susan E. [3 ,5 ,7 ]
Tamimi, Rulla M. [1 ,3 ,5 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[2] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
[5] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA
[6] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
[7] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Div Biostat & Epidemiol, Amherst, MA 01003 USA
基金
美国国家卫生研究院;
关键词
Benign breast disease; Breast cancer; Breast pathology; Nested case-control; Radial scars; ATYPICAL HYPERPLASIA; MALIGNANT BREAST; NUCLEAR-ORGANIZATION; TUBULAR CARCINOMA; TISSUE STRUCTURE; GENE-EXPRESSION; DISEASE; LESIONS; BIOPSIES; WOMEN;
D O I
10.1007/s10549-013-2535-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Radial scars (RS) are benign proliferative lesions associated with an increased risk of subsequent breast cancer. However, it remains unclear whether RS are an independent risk factor for breast cancer or whether their association with breast cancer is due to their common occurrence with other proliferative lesions known to increase breast cancer risk. We performed an updated analysis of the association between RS and subsequent breast cancer risk in a nested case-control study among 460 cases and 1,792 controls with benign breast disease (BBD) in the Nurses' Health Studies. Logistic regression was used to estimate associations between RS in BBD biopsy specimens and breast cancer risk, adjusted for matching factors and breast cancer risk factors, including histologic category of concurrent BBD. In multivariable models prior to adjustment for histologic category of BBD, RS were associated with a twofold increased risk of breast cancer (odds ratio (OR) = 2.0; 95 % confidence interval (95 % CI) 1.4, 2.8). This association was attenuated but still significant after adjustment for BBD histologic category (OR = 1.6; 95 % CI 1.1, 2.3). In models adjusted for BBD histologic category and other covariates, risk appeared greater among women with multiple RS (1 RS, OR = 1.5; 95 % CI 0.9, 2.3; a parts per thousand yen2 RS, OR = 2.7; 95 % CI 1.5, 5.0; p-heterogeneity = 0.12). There were also suggestions of a greater risk associated with RS among women age a parts per thousand yen50 years at biopsy (p-heterogeneity = 0.07) and for estrogen receptor-negative/progesterone receptor-negative tumors compared with other hormone receptor subtypes (p-heterogeneity = 0.19). RS appear to be an independent histologic risk factor for breast cancer. Larger studies are needed to further evaluate whether risk is increased when multiple RS are present and whether associations vary by age at biopsy or by hormone receptor status of the breast tumor.
引用
收藏
页码:277 / 285
页数:9
相关论文
共 50 条
  • [21] Healthful and Unhealthful Plant-Based Diets and Risk of Breast Cancer in US Women: Results from the Nurses' Health Studies
    Romanos-Nanclares, Andrea
    Willett, Walter C.
    Rosner, Bernard A.
    Collins, Laura C.
    Hu, Frank B.
    Toledo, Estefania
    Eliassen, A. Heather
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (10) : 1921 - 1931
  • [22] Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia - Results from the Nurses' Health Study
    Collins, Laura C.
    Baer, Heather J.
    Tamimi, Rulla M.
    Connolly, James L.
    Colditz, Graham A.
    Schnitt, Stuart J.
    CANCER, 2007, 109 (02) : 180 - 187
  • [23] Plasma enterolactone and breast cancer risk in the Nurses' Health Study II
    Xie, Jing
    Tworoger, Shelley S.
    Franke, Adrian A.
    Terry, Kathryn L.
    Rice, Megan S.
    Rosner, Bernard A.
    Willett, Walter C.
    Hankinson, Susan E.
    Eliassen, A. Heather
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (03) : 801 - 809
  • [24] Caregiver burden and risk of epithelial ovarian cancer in the Nurses' Health Studies
    Barnard, Mollie E.
    Poole, Elizabeth M.
    Huang, Tianyi
    Sood, Anil K.
    Kubzansky, Laura D.
    Tworoger, Shelley S.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2024, 194 (02) : 362 - 369
  • [25] Benign breast disease and subsequent breast cancer: English record linkage studies
    Goldacre, M. J.
    Abisgold, J. D.
    Yeates, D. G. R.
    Vessey, M. P.
    JOURNAL OF PUBLIC HEALTH, 2010, 32 (04) : 565 - 571
  • [26] Urinary Melatonin Concentration and the Risk of Breast Cancer in Nurses' Health Study II
    Brown, Susan B.
    Hankinson, Susan E.
    Eliassen, A. Heather
    Reeves, Katherine W.
    Qian, Jing
    Arcaro, Kathleen F.
    Wegrzyn, Lani R.
    Willett, Walter C.
    Schernhammer, Eva S.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2015, 181 (03) : 155 - 162
  • [27] Importance of a Personal History of Breast Cancer as a Risk Factor for the Development of Subsequent Breast Cancer: Results From Screening Breast MRI
    Schacht, David V.
    Yamaguchi, Ken
    Lai, Jessica
    Kulkarni, Kirti
    Sennett, Charlene A.
    Abe, Hiroyuki
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2014, 202 (02) : 289 - 292
  • [28] No association between cSHMT genotypes and the risk of breast cancer in the Nurses' Health Study
    Bentley, A. R.
    Raiszadeh, F.
    Stover, P. J.
    Hunter, D. J.
    Hankinson, S. E.
    Cassano, P. A.
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2010, 64 (01) : 108 - 110
  • [29] Active and passive smoking in breast cancer: Prospective results from the Nurses' Health Study
    Egan, KM
    Stampfer, MJ
    Hunter, D
    Hankinson, S
    Rosner, BA
    Holmes, M
    Willett, WC
    Colditz, GA
    EPIDEMIOLOGY, 2002, 13 (02) : 138 - 145
  • [30] Statin Use and Breast Cancer Risk in the Nurses' Health Study
    Borgquist, Signe
    Tamimi, Rulla M.
    Chen, Wendy Y.
    Garber, Judy E.
    Eliassen, A. Heather
    Ahern, Thomas P.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (01) : 201 - 206